The Novel RXR Agonist MSU-42011 Differentially Regulates Gene Expression in Mammary Tumors of MMTV-Neu Mice

Retinoid X receptor (RXR) agonists, which activate the RXR nuclear receptor, are effective in multiple preclinical cancer models for both treatment and prevention. While RXR is the direct target of these compounds, the downstream changes in gene expression differ between compounds. RNA sequencing wa...

Descripción completa

Detalles Bibliográficos
Autores principales: Reich, Lyndsey A., Leal, Ana S., Ellsworth, Edmund, Liby, Karen T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10001983/
https://www.ncbi.nlm.nih.gov/pubmed/36901727
http://dx.doi.org/10.3390/ijms24054298

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10001983/
https://www.ncbi.nlm.nih.gov/pubmed/36901727
http://dx.doi.org/10.3390/ijms24054298

Ejemplares similares